The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy

Dephosphorylation Sting
DOI: 10.1016/j.celrep.2025.115605 Publication Date: 2025-04-17T18:35:39Z